CSPC Innovation Pharmaceutical Co Ltd Class A (300765) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.009x

Based on the latest financial reports, CSPC Innovation Pharmaceutical Co Ltd Class A (300765) has a cash flow conversion efficiency ratio of -0.009x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-25.98 Million ≈ $-3.80 Million USD) by net assets (CN¥2.80 Billion ≈ $409.04 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300765 equity to assets ratio to measure how much of total assets are equity-financed.

CSPC Innovation Pharmaceutical Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how CSPC Innovation Pharmaceutical Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 300765 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

CSPC Innovation Pharmaceutical Co Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CSPC Innovation Pharmaceutical Co Ltd Class A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Telekom Malaysia Bhd KLSE:4863	0.023x
Konfoong Materials International Co Ltd SHE:300666	0.018x
Pearson plc F:PESA	0.054x
Gotion High tech Co Ltd SHE:002074	0.004x
Capital Power Corporation TO:CPX	0.064x
UGI Corporation NYSE:UGI	0.122x
SM Energy Co NYSE:SM	0.093x
NIBE Industrier AB (publ) ST:NIBE-B	0.100x

Annual Cash Flow Conversion Efficiency for CSPC Innovation Pharmaceutical Co Ltd Class A (2014–2025)

The table below shows the annual cash flow conversion efficiency of CSPC Innovation Pharmaceutical Co Ltd Class A from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see market value of CSPC Innovation Pharmaceutical Co Ltd Cl.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.80 Billion ≈ $409.04 Million	CN¥-195.69 Million ≈ $-28.64 Million	-0.070x	+74.52%
2024-12-31	CN¥4.50 Billion ≈ $657.90 Million	CN¥-1.24 Billion ≈ $-180.73 Million	-0.275x	-262.45%
2023-12-31	CN¥5.48 Billion ≈ $802.37 Million	CN¥927.24 Million ≈ $135.68 Million	0.169x	+4.10%
2022-12-31	CN¥3.94 Billion ≈ $577.16 Million	CN¥640.72 Million ≈ $93.76 Million	0.162x	+83.40%
2021-12-31	CN¥3.30 Billion ≈ $482.55 Million	CN¥292.09 Million ≈ $42.74 Million	0.089x	-31.82%
2020-12-31	CN¥2.69 Billion ≈ $393.18 Million	CN¥349.07 Million ≈ $51.08 Million	0.130x	-0.51%
2019-12-31	CN¥2.42 Billion ≈ $353.44 Million	CN¥315.38 Million ≈ $46.15 Million	0.131x	-18.30%
2018-12-31	CN¥999.35 Million ≈ $146.24 Million	CN¥159.73 Million ≈ $23.37 Million	0.160x	+9327.66%
2017-12-31	CN¥766.93 Million ≈ $112.23 Million	CN¥1.30 Million ≈ $190.26K	0.002x	-99.29%
2016-12-31	CN¥572.02 Million ≈ $83.70 Million	CN¥137.27 Million ≈ $20.09 Million	0.240x	+34.25%
2015-12-31	CN¥626.83 Million ≈ $91.72 Million	CN¥112.05 Million ≈ $16.40 Million	0.179x	+2.85%
2014-12-31	CN¥537.16 Million ≈ $78.60 Million	CN¥93.36 Million ≈ $13.66 Million	0.174x	--

About CSPC Innovation Pharmaceutical Co Ltd Class A

SHE:300765 China Packaged Foods

Market Cap

$7.47 Billion

CN¥51.01 Billion CNY

Market Cap Rank

#2717 Global

#318 in China

Share Price

CN¥36.32

Change (1 day)

-4.47%

52-Week Range

CN¥23.23 - CN¥58.32

All Time High

CN¥189977.21